Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment

<p>Abstract</p> <p>Background</p> <p>The effects of pan-peroxisome proliferator-activated receptor (PPAR) ligand bezafibrate on N-terminal pro-B type natriuretic peptide (ProBNP) level in patients with coronary artery disease (CAD) is unknown. The current study aimed to investigate the long-term eff...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Matas Zipora, Schwammenthal Ehud, Adler Yehuda, Fisman Enrique Z, Goldberg Ilan, Boyko Valentin, Inoue Teruo, Node Koichi, Behar Solomon, Tenenbaum Alexander
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	BMC 2009-01-01
Cyfres:	Cardiovascular Diabetology
Mynediad Ar-lein:	http://www.cardiab.com/content/8/1/5
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!